Mike B Barnkob and his team reported that NRP1 KO mice and genetic models of Sema3A in cancer cells, T cell expression of NRP1, and tumor cell expression of Sema3A can control CD8+ T cell infiltration. This evidence concerns the gene SEMA3A and cancer.